Company Filing History:
5 out of 9 
1 out of 13 
1 out of 9 
Years Active: 2014-2025
Title: Matthias Mack: Innovator in Antibody Research
Introduction
Matthias Mack is a prominent inventor based in Wuppertal, Germany. He has made significant contributions to the field of antibody research, holding a total of 8 patents. His work focuses on developing innovative solutions for various diseases through targeted antibody therapies.
Latest Patents
Mack's latest patents include groundbreaking research on antibodies targeting IL3. This patent discloses antibodies and antibody fragments that are specific for IL3, along with nucleic acids encoding these antibodies and pharmaceutical compositions that include them. The antibodies developed in this research are capable of blocking IL-3 activity in target cells, making them useful for preventing and treating diseases associated with elevated levels of IL3, such as inflammatory diseases, autoimmune diseases, fibrotic diseases, and hematologic malignancies.
Another significant patent involves antibodies targeting CCR2. This patent details antibodies and antibody fragments that are specific for CCR2, which deplete CCR2-positive cells and block MCP-1 (CCL2) induced downregulation of CCR2 on human leukocytes. These antibodies possess advantageous biophysical properties and are beneficial for treating inflammatory diseases, autoimmune diseases, and hematologic malignancies.
Career Highlights
Throughout his career, Matthias Mack has worked with esteemed institutions such as Universitätsklinikum Regensburg and Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts. His research has been instrumental in advancing the understanding and treatment of various medical conditions through innovative antibody therapies.
Collaborations
Mack has collaborated with notable colleagues, including Hilke Brühl and Kerstin Renner. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Matthias Mack is a distinguished inventor whose work in antibody research has the potential to transform the treatment of several diseases. His innovative patents and collaborations highlight his commitment to advancing medical science through targeted therapies.